Urenco Isotopes provides the world with stable and medical isotopes for medical, research and industry uses.
Visit our Isotopes websiteSee what actions we are taking to achieve net zero by 2040 in our net zero transition plan.
Read it hereOur significant order book increase in a growing market is a great sign of confidence.
Read our latest reportUrenco is pleased to announce the appointment of Dr Jörg Harren as Managing Director of Urenco Deutschland, effective 1 October 2021.
Dr Harren will succeed Dr Joachim Ohnemus who will retire later this year.
Dr Harren has more than 20 years of experience in the chemical industry. He joins Urenco from Evonik, where he served as Site Manager of one of Europe’s largest chemical sites. Dr Harren brings a wealth of knowledge and experience in research and development, as well as technology, which supports Urenco’s strategic objectives.
Dr Harren gained a PhD in Organic Chemistry from the University of Bonn.
The park at our site in Gronau will become the second biggest ground-mounted solar installation in the region.
Read more Urenco launches solar parkThe park at our site in Gronau will become the second biggest ground-mounted solar installation in the region.
Read more Urenco launches solar parkWe have supported two young people who went on an expedition to the North Cape to conduct research.
Read more Urenco supports students’ climate change expeditionWe have supported two young people who went on an expedition to the North Cape to conduct research.
Read more Urenco supports students’ climate change expeditionAbout Urenco
Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.
With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries